SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.50-2.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biotech Jim who wrote (16604)3/7/1998 9:02:00 PM
From: Henry Niman  Read Replies (2) of 32384
 
BJ, I just received a Keystone/Lake Tahoe update from a "very reliable" source. I would appreciate any verification or additions that you could add. I think that the small molecule may actually target the receptor itself. The receptor in question is G-CSF and the small molecule is very specific for that receptor. It is a mouse system (not sure, but the molecule may be so specific that it only interacts with the mouse receptor), but most at LGND and SBH are EXTREMELY excited. I'm sure that LGND has filed patents to fend off the me toos, but they are probably in a feeding frenzy by now.

The paper has only been submitted, so it doesn't look good for March Madness, but LGND's got a pretty full plate for this month already.

Scientists and big Pharmas know that this is big time news. It will be interesting to see how long it takes for the street to figure it out. However, LGNDers should be all smiles.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext